Skip to main content

The cost of treating high blood pressure in general practice in France

Abstract

In this study, the cost of having high blood pressure treated by French general practitioners was estimated, using an analysis of the computerized records for 28,015 patients with either hypertension or history of hypertension over three years. Costs due to visits, drugs, and complementary tests were included. The average annual cost of treatment was 597€ (SD 377€). The annual average cost of drugs was 447€, and antihypertensive drugs 258€. The average annual cost of patients who were controlled throughout the period was 537€, patients who were normalized cost 595€, and patients who deteriorated cost 612€.

This is a preview of subscription content, access via your institution.

References

  1. 1.

    Agence Nationale d’Accréditation et d’Evaluation en Santé Management of adults with essential hypertension.: Clinical Practice Recommendations and Economic Data. ANAES, Paris (2000)

  2. 2.

    Alexander, M., Tekawa, I., Hunkeler, E., Fireman, B., Rowell, R., Selby, J. et al.: Evaluating hypertension control in a managed care setting. Arch. Intern. Med 159, 2673–2677 (1999)

    Article  Google Scholar 

  3. 3.

    Barrie, W.: Cost-effective therapy for hypertension. West. J. Med. 164, 303–309 (1996)

    Google Scholar 

  4. 4.

    Berlowitz, D.R., Ash, A.S., Hickey, E.C., Friedman, R.H., Glickman, M., Kader, B., Moskowitz, M.A.: Inadequate management of blood pressure in a hypertensive population. N. Engl. J. Med. 339, 1957–1963 (1998)

    Article  Google Scholar 

  5. 5.

    Burt, V.L., Cutler, J.A., Higgins, M., Horan, M.J., Labarthe, D., Whelton, P. et al.: Trends in the prevalence, awareness, treatment, and control of hypertension in the adult US population. Data from the Health Examinations Surveys, 1960 to 1991. Hypertension 26, 60–69 (1995)

    Google Scholar 

  6. 6.

    Cambou, J-P.: Hypertension artérielle essentielle, risque absolu et décision d’intervention chez le malade hypertendu. Rev. Prat. 49, 503–509 (1999)

    Google Scholar 

  7. 7.

    Chalmers, J., Chusid, P., Cohn, J. et al.: Practice guidelines for primary care physicians. WHO/ISH Hypertension Guidelines. WHO, Geneva (1999)

  8. 8.

    Day, K., Booyens, S.: The cost-effectiveness of managed care regarding chronic medicine prescriptions in a selected medical scheme. Curationis 21, 65–70 (1998)

    Google Scholar 

  9. 9.

    Editions du VIDAL.: Dictionnaire VIDAL 2000, 76th edn. Editions du VIDAL, Paris (2000)

  10. 10.

    Egan, B.M., Lackland, D.T., Williams, B., Gunter, N., Tocharoen, A., Beardon, L.: Health care improvement and cost reduction opportunities in hypertensive medicaid beneficiaries. J. Clin. Hypertens. 3,279–82, 318 (2001)

    Google Scholar 

  11. 11.

    Fender, P., Païta, M., Salavane, B., Ganay, D., Allemand, H.: Dépenses du Régime général de l’Assurance-Maladie en 1994 pour les trente affections de longue durée. Santé Publique 12, 5–19 (2000)

    Google Scholar 

  12. 12.

    Frérot, L., Le Fur, P., Le Pape, A., Sermet, C.: L’hypertension artérielle en France : prévalence et prise en charge thérapeutique. Série résultats—Report n° 1999/09. CREDES, Paris (1999)

  13. 13.

    Hajjar, I., Kotchen, T.A.: Trends in prevalence, awareness, treatment, and control of hypertension in the United States, 1988–2000. JAMA 2090, 199–206 (2003)

    Article  Google Scholar 

  14. 14.

    Mar, J., Pastor, R., Abasolo, R.: Costs analysis of ambulatory blood pressure monitoring in mild hypertension. Gac. Sanit. 13, 384–90 (1999)

    Google Scholar 

  15. 15.

    Paramore, L.C., Halpern, M.T., Lapuerta, P. et al.: Impact of poorly controlled hypertension on healthcare resource utilization and cost. Am. J. Manag. Care. 7, 389–398 (2001)

    Google Scholar 

  16. 16.

    Poggi, L., Chamontin, B., Lang, T. et al.: Prévalence, traitement et contrôle de l’hypertension artérielle chez les consultants en médecine générale en France en 1994. Arch. Mal. Cœur. Vaiss. 89, 1075–80 (1996)

    Google Scholar 

  17. 17.

    Pozuelo, G., Vergeles-Blanca, J.M., Molina, L., Cordero, J.A., Buitrago, F.: Drug savings and the outpatient monitoring of arterial pressure in a group of hypertensive patients. Aten. Primaria. 15, 329–32 (1997)

    Google Scholar 

  18. 18.

    Schueler K.: Cost-effectiveness issues in hypertension control. Can. J. Public. Health. 85, S54–6 (1994)

    Google Scholar 

  19. 19.

    Joint National Committee on Prevention, Detection, Evaluation, and Treatment of High Blood Pressure.: Sixth report. Arch. Intern. Med. 157, 2413–2446 (1997)

  20. 20.

    Union des Caisses Nationales de Sécurité Sociale Nomenclature Générale des Actes Professionnels.: Nomenclature des Actes de Biologie Médicale. UCANSS, Paris (2000)

  21. 21.

    World Hypertension League. Economics of hypertension control. Bull. World. Health. Organ. 73, 417–24 (1995)

    Google Scholar 

  22. 22.

    WHO-International society of hypertension guidelines for the management of hypertension. J Hypertens. 17, 151–83 (1999)

    Google Scholar 

  23. 23.

    Wolf-Maier, K., Cooper, R.S., Banegas, J.R., Giampaoli, S., Hense, H.W., Joffres, M. et al.: Hypertension prevalence and blood pressure in 6 European countries, Canada, and the United States. JAMA 289, 2363–2369 (2003)

    Article  Google Scholar 

  24. 24.

    Wolf-Maier, K., Cooper, R.S., Kramer, H., Banegas, J.R., Giampaoli, S., Joffres, M. et al.: Hypertension treatment and control in five European countries, Canada and the United States. Hypertension 43, 10–17 (2004)

    Article  Google Scholar 

Download references

Acknowledgments

This study was funded by a research grant from Bristol Myers Squibb, France.

Author information

Affiliations

Authors

Corresponding author

Correspondence to Gérard de Pouvourville.

Rights and permissions

Reprints and Permissions

About this article

Cite this article

Tibi-Levy, Y., de Pouvourville, G., Westerloppe, J. et al. The cost of treating high blood pressure in general practice in France. Eur J Health Econ 9, 229–236 (2008). https://doi.org/10.1007/s10198-007-0065-2

Download citation

Keywords

  • Hypertension
  • Cost
  • Family practice

JEL Classification

  • I12